Filing Details
- Accession Number:
- 0000885590-14-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-19 16:33:19
- Reporting Period:
- 2014-03-17
- Filing Date:
- 2014-03-19
- Accepted Time:
- 2014-03-19 16:33:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1502213 | Roswell Robert Chai-Onn | 2150 St. Elzear Blvd. West Laval A8 H7L 4A8 | Evp, Gen. Couns. & Corp. Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2014-03-17 | 5,000 | $6.45 | 28,999 | No | 4 | M | Direct | |
Common Stock, No Par Value | Disposition | 2014-03-17 | 5,000 | $141.72 | 23,999 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Non-Qualified Stock | Disposition | 2014-03-17 | 5,000 | $0.00 | 5,000 | $6.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,203 | 2008-08-09 | 2014-08-09 | No | 4 | M | Direct |
Footnotes
- This number represents options exercised and sold pursuant to a 10b5-1 trading plan.
- This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $141.63 and $141.80. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- The options vested one-fourth per year over four years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant, and the fourth vest date falling fourth anniversary of the grant.